Effect of acetylspiramycin on plasma concentration of baicalin in rats
Sun Hong
Abstract
Sun Hong
Abstract
Objective; To evaluate the effect of oral acetylspiramycin on the plasma concentration of baicalin in rats. Methods; The rats were randomly supplemented with baicalin ( 34 mg·kg-1,ig)alone or combination of acetylspiramycin (333 mg·kg-1, ig, bid, 3d) and baicalin (34 mg·kg-1, ig). Plasma concentrations of baicalin in the 2 groups were determined by HPLC with electrochemical detection (ECD).The pharmacokinetic parameters were evaluated by statistical analysis. Results; The pharmaco-kinetics parameters of the combination- and mono-regimen were Cmax(785. 84±401. 23)vs. (2645.62±601.42)ng·mL-1, and AUC0-24h( 11 564.27±5 585.65) vs. (28 952.90±5 731.42)ng·h·mL-1, respectively; the P values showed significant difference (P 0. 05). Conclusion; Adjuvant therapy of acetylspiramycin with baicalin significantly intervenes the plasma concentration of baicalin.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective; To evaluate the effect of oral acetylspiramycin on the plasma concentration of baicalin in rats. Methods; The rats were randomly supplemented with baicalin ( 34 mg·kg-1,ig)alone or combination of acetylspiramycin (333 mg·kg-1, ig, bid, 3d) and baicalin (34 mg·kg-1, ig). Plasma concentrations of baicalin in the 2 groups were determined by HPLC with electrochemical detection (ECD).The pharmacokinetic parameters were evaluated by statistical analysis. Results; The pharmaco-kinetics parameters of the combination- and mono-regimen were Cmax(785. 84±401. 23)vs. (2645.62±601.42)ng·mL-1, and AUC0-24h( 11 564.27±5 585.65) vs. (28 952.90±5 731.42)ng·h·mL-1, respectively; the P values showed significant difference (P 0. 05). Conclusion; Adjuvant therapy of acetylspiramycin with baicalin significantly intervenes the plasma concentration of baicalin.
Key concepts: Baicalin, Cmax, Plasma concentration, Chemistry, Significant difference, Pharmacokinetics, High-performance liquid chromatography, Pharmacology